Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,415 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL

NCT04560322

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

NCT05645107

Conditions
Agammaglobulinemia, B-cell Chronic Lymphocytic Leukemia, Bacterial Infections, +25 more
Locations
  • GC2202 Study Site 115 Huntington Park, California, United States
  • GC2202 Study Site 103 St. Petersburg, Florida, United States
  • GC2202 Study Site 111 Bethesda, Maryland, United States
  • GC2202 Study Site 109 Greenville, North Carolina, United States
View all 62 locations
View Trial Details
Recruiting

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT06428019

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Arizona Oncology - Tucson - Rudasill /ID# 267552 Tucson, Arizona, United States
  • Southern VA Health Care System /ID# 266254 Tucson, Arizona, United States
  • UCSF FRESNO/Community Cancer Institute /ID# 270874 Clovis, California, United States
  • Valkyrie Clinical Trials /ID# 268151 Los Angeles, California, United States
View all 70 locations
View Trial Details
Recruiting

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

NCT05010005

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations
  • University of Miami (Data Collection Only) Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Recruiting

Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT06419634

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Yale-New Haven Hospital New Haven, Connecticut, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Local Institution - 0007 Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 16 locations
View Trial Details

Related conditions